circRNA basic information
circBase ID: hsa_circ_0027345
Name: hsa_circ_LRIG3
Synonym: -
Host Gene: LRIG3
Genomic location(hg19): chr12:59277301-59308117:-
Genomic location(hg38): chr12:58883519-58914336:-
Subcellular localization: nucleus
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0007256
MONDO name: hepatocellular carcinoma
Disease details: hepatocellular carcinoma
Disease DO ID:
684, 686
Disease MeSH ID:
D006528
Disease NCIt ID:
C3099
Disease ICD11 ID:
1294035808
Disease OMIM ID:
114550
Species: Human
Species details: Homo sapiens
Tissue specimen:

HCC tissues; adjacent normal tissues; plasma

Cell lines:

SNU-423; HepG2; Hep3B; Huh7; SMMC-7721; MHCC-97 L; LO2

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: EZH2, STAT3, p-STAT3
Associated microRNA: -
Biological function: Promotes HCC cell proliferation, migration and invasion; reduces apoptosis; enhances tumorigenicity and metastasis in vivo.
Molecular mechanism: Acts as a nuclear scaffold forming a ternary complex with EZH2 and STAT3, promoting EZH2-induced STAT3 methylation and phosphorylation to activate STAT3 signaling; activated STAT3 binds the circ-LRIG3 promoter to increase circ-LRIG3 transcription, creating a positive feedback loop.
Biological pathway or process:

JAK/STAT (promotes); proliferation (promotes); migration (promotes); invasion (promotes); apoptosis (inhibits); metastasis (promotes)

Detected method:
Q
Validation methods:

Back-Splice Junction PCR / divergent primers PCR; RNase R Treatment; Sanger Sequencing; Actinomycin D / DRB Stability Assay; RT-qPCR; FISH / smFISH; Clinical Sample Validation; Transfection; CCK8; EdU Staining; Transwell Assay; Annexin V/PI Flow Cytometry; RNA-seq; Bioinformatics Analysis; RIP (RNA Immunoprecipitation); RNA Pull-Down; Co-IP; IF (Immunofluorescence); ChIP / ChIP-seq; Luciferase Reporter Assay; Western Blot; IHC (Immunohistochemistry); In Vivo Animal Model; H&E Staining; TUNEL; Survival Analysis; ROC Analysis

Clinical significance:

High circ-LRIG3 is associated with aggressive clinicopathological features, is an independent risk prognostic factor for overall survival, and plasma circ-LRIG3 is a sensitive and specific non-invasive diagnostic indicator for HCC.

Description:

circ-LRIG3 (hsa_circ_0027345) is upregulated in HCC tissues/cells/plasma and functions as an oncogenic nuclear circRNA. It scaffolds EZH2 and STAT3 to enhance STAT3 methylation/phosphorylation and activate STAT3 signaling, and activated STAT3 increases circ-LRIG3 transcription to form a positive feedback loop, promoting proliferation, invasion and metastasis and inhibiting apoptosis. Clinically, high circ-LRIG3 indicates poor prognosis and plasma circ-LRIG3 shows diagnostic potential for HCC.

Confidence score:

0.9014

Other information
Title:

A novel circular RNA circ-LRIG3 facilitates the malignant progression of hepatocellular carcinoma by modulating the EZH2/STAT3 signaling.

Journal: Journal of experimental & clinical cancer research : CR
Published: 2020
PubMed ID: 33222697
Study type:

combined biological and clinical study

Data availability: GSE154021
Code availability: -